Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity-Reference-Cited by-同舟云学术

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

Published:2018-06 Issue:11 Volume:23 Page:3262-3274
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Wang David,Quiros Jason,Mahuron Kelly,Pai Chien-Chun,Ranzani Valeria,Young Arabella,Silveria Stephanie,Harwin Tory,Abnousian Arbi,Pagani Massimiliano,Rosenblum Michael D.,Van Gool Frederic,Fong Lawrence,Bluestone Jeffrey A.,DuPage Michel

Funder

NIH

Associazione Italiana per la Ricerca sul Cancro

Parker Institute for Cancer Immunotherapy

Frank A. Campini Foundation

NIH/National Cancer Institute

Helen Hay Whitney Foundation

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference54 articles.

1. Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells;Arvey;Nat. Immunol.,2014

2. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response;Bailey-Bucktrout;Immunity,2013

3. Transient regulatory T cell ablation deters oncogene-driven breast cancer and enhances radiotherapy;Bos;J. Exp. Med.,2013

4. Depleting intratumoral CD4+CD25+ regulatory T cells via FasL protein transfer enhances the therapeutic efficacy of adoptive T cell transfer;Chen;Cancer Res.,2007

5. Tregs and rethinking cancer immunotherapy;Curiel;J. Clin. Invest.,2007

Cited by 224 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epigenetics and immunotherapy in colorectal cancer: progress and promise;Clinical Epigenetics;2024-09-10

2. Infiltrating treg reprogramming in the tumor immune microenvironment and its optimization for immunotherapy;Biomarker Research;2024-09-04

3. Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiation;Cell Reports;2024-09

4. Dysregulated T-cell homeostasis and decreased CD30+ Treg proliferating in aplastic anemia;Heliyon;2024-08

5. Fragile Treg cells: Traitors in immune homeostasis?;Pharmacological Research;2024-08